◆Genexine=Decision to dispose of shares in Chinese biotech company I-Mab worth 36 billion KRW for the purpose of funding major pipeline clinical development and operations
◆Iruda=Entered into a trust contract with KB Securities for the acquisition of treasury shares worth 1 billion KRW
◆Webs=KOSDAQ Market Headquarters requested an inquiry disclosure related to significant market fluctuations
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
